NCG 5.0: Updates of a manually curated repository of cancer genes and associated properties from cancer mutational screenings

Nucleic Acids Research

Volumn 44, Issue D1, 2016, Pages D992-D999

  An, Omer ^a   Dall'Olio, Giovanni M ^a   Mourikis, Thanos P ^a   Ciccarelli, Francesca D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CANCER SCREENING; DRUG RESPONSE; EXPERIMENTAL STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE INTERACTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; MUTATIONAL ANALYSIS; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; PUBLICATION; RNA INTERFERENCE; SCIENTIFIC LITERATURE; SURVIVAL ANALYSIS; TUMOR GENE; TUMOR XENOGRAFT; VALIDATION STUDY; GENETIC DATABASE; GENETICS; MOLECULAR GENETICS; MUTATION; NEOPLASM;

DATA CURATION; DATABASES, GENETIC; GENES, NEOPLASM; HUMANS; MOLECULAR SEQUENCE ANNOTATION; MUTATION; NEOPLASMS;

EID: 84976893968     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv1123     Document Type: Article

References (59)

1. Stratton, M. R., Campbell, P. J. and Futreal, P. A. (2009) The cancer genome. Nature, 458, 719-724.
2. Garraway, L. A. and Lander, E. S. (2013) Lessons from the cancer genome. Cell, 153, 17-37.
3. Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A. Jr and Kinzler, K. W. (2013) Cancer genome landscapes. Science, 339, 1546-1558.
4. Syed, A. S., D'Antonio, M. and Ciccarelli, F. D. (2010) Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes. Nucleic Acids Res., 38, D670-D675.
5. Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N. and Stratton, M. R. (2004) A census of human cancer genes. Nat. Rev. Cancer, 4, 177-183.
6. Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A. et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature, 499, 214-218.
7. Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A. et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature, 502, 333-339.
8. An, O., Pendino, V., D'Antonio, M., Ratti, E., Gentilini, M. and Ciccarelli, F. D. (2014) NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. Database, 2014, bau015.
9. Dees, N. D., Zhang, Q., Kandoth, C., Wendl, M. C., Schierding, W., Koboldt, D. C., Mooney, T. B., Callaway, M. B., Dooling, D., Mardis, E. R. et al. (2012) MuSiC: identifying mutational significance in cancer genomes. Genome Res., 22, 1589-1598.
10. Shimizu, A., Asakawa, S., Sasaki, T., Yamazaki, S., Yamagata, H., Kudoh, J., Minoshima, S., Kondo, I. and Shimizu, N. (2003) A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. Biochem. Biophys. Res. Commun., 309, 143-154.
11. Liu, P., Morrison, C., Wang, L., Xiong, D., Vedell, P., Cui, P., Hua, X., Ding, F., Lu, Y., James, M. et al. (2012) Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis, 33, 1270-1276.
12. Rambaldi, D., Giorgi, F. M., Capuani, F., Ciliberto, A. and Ciccarelli, F. D. (2008) Low duplicability and network fragility of cancer genes. Trends Genet., 24, 427-430.
13. Pruitt, K. D., Brown, G. R., Hiatt, S. M., Thibaud-Nissen, F., Astashyn, A., Ermolaeva, O., Farrell, C. M., Hart, J., Landrum, M. J., McGarvey, K. M. et al. (2014) RefSeq: an update on mammalian reference sequences. Nucleic Acids Res., 42, D756-D763.
14. Powell, S., Forslund, K., Szklarczyk, D., Trachana, K., Roth, A., Huerta-Cepas, J., Gabaldon, T., Rattei, T., Creevey, C., Kuhn, M. et al. (2014) eggNOG v4.0: nested orthology inference across 3686 organisms. Nucleic Acids Res., 42, D231-D239.
15. D'Antonio, M. and Ciccarelli, F. D. (2011) Modification of gene duplicability during the evolution of protein interaction network. PLoS Comput. Biol., 7, e1002029.
16. Domazet-Loso, T. and Tautz, D. (2008) An ancient evolutionary origin of genes associated with human genetic diseases. Mol. Biol. Evol., 25, 2699-2707.
17. Domazet-Loso, T. and Tautz, D. (2010) Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa. BMC Biol., 8, 66.
18. Chatr-Aryamontri, A., Breitkreutz, B. J., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O'Donnell, L. et al. (2015) The BioGRID interaction database: 2015 update. Nucleic Acids Res., 43, D470-D478.
19. Orchard, S., Ammari, M., Aranda, B., Breuza, L., Briganti, L., Broackes-Carter, F., Campbell, N. H., Chavali, G., Chen, C., del-Toro, N. et al. (2014) The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res., 42, D358-D363.
20. Salwinski, L., Miller, C. S., Smith, A. J., Pettit, F. K., Bowie, J. U. and Eisenberg, D. (2004) The Database of Interacting Proteins: 2004 update. Nucleic Acids Res., 32, D449-D451.
21. Keshava Prasad, T. S., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S., Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, B., Venugopal, A. et al. (2009) Human Protein Reference database-2009 update. Nucleic Acids Res., 37, D767-D772.
22. Ruepp, A., Waegele, B., Lechner, M., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C. and Mewes, H. W. (2010) CORUM: the comprehensive resource of mammalian protein complexes-2009. Nucleic Acids Res., 38, D497-D501.
23. Milacic, M., Haw, R., Rothfels, K., Wu, G., Croft, D., Hermjakob, H., D'Eustachio, P. and Stein, L. (2012) Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers, 4, 1180-1211.
24. Hsu, S. D., Tseng, Y. T., Shrestha, S., Lin, Y. L., Khaleel, A., Chou, C. H., Chu, C. F., Huang, H. Y., Lin, C. M., Ho, S. Y. et al. (2014) miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res., 42, D78-D85.
25. Xiao, F., Zuo, Z., Cai, G., Kang, S., Gao, X. and Li, T. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res., 37, D105-D110.
26. Melé, M., Ferreira, P. G., Reverter, F., DeLuca, D. S., Monlong, J., Sammeth, M., Young, T. R., Goldmann, J. M., Pervouchine, D. D., Sullivan, T. J. et al. (2015) Human genomics. The human transcriptome across tissues and individuals. Science, 348, 660-665.
27. Uhlén, M., Fagerberg, L., Hallstrom, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, A., Kampf, C., Sjostedt, E., Asplund, A. et al. (2015) Proteomics. Tissue-based map of the human proteome. Science, 347, 1260419.
28. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehar, J., Kryukov, G. V., Sonkin, D. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
29. Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J. et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature, 483, 570-575.
30. Klijn, C., Durinck, S., Stawiski, E. W., Haverty, P. M., Jiang, Z., Liu, H., Degenhardt, J., Mayba, O., Gnad, F., Liu, J. et al. (2015) A comprehensive transcriptional portrait of human cancer cell lines. Nat. Biotechnol., 33, 306-312.
31. D'Antonio, M. and Ciccarelli, F. D. (2013) Integrated analysis of recurrent properties of cancer genes to identify novel drivers. Genome Biol., 14, R52.
32. Letunic, I., Doerks, T. and Bork, P. (2015) SMART: recent updates, new developments and status in 2015. Nucleic Acids Res., 43, D257-D260.
33. Griffith, M., Griffith, O. L., Coffman, A. C., Weible, J. V., McMichael, J. F., Spies, N. C., Koval, J., Das, I., Callaway, M. B., Eldred, J. M. et al. (2013) DGIdb: mining the druggable genome. Nat. Methods, 10, 1209-1210.
34. Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J. and Bork, P. (2014) STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res., 42, D401-D407.
35. Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Kruger, F. A., Light, Y., Mak, L., McGlinchey, S. et al. (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res., 42, D1083-D1090.
36. D'Antonio, M., Guerra, R. F., Cereda, M., Marchesi, S., Montani, F., Nicassio, F., Di Fiore, P. P. and Ciccarelli, F. D. (2013) Recessive cancer genes engage in negative genetic interactions with their functional paralogs. Cell Rep., 5, 1519-1526.
37. Cheng, F., Jia, P., Wang, Q., Lin, C. C., Li, W. H. and Zhao, Z. (2014) Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome. Mol. Biol. Evol., 31, 2156-2169.
38. Haemmerle, R., Phaltane, R., Rothe, M., Schroder, S., Schambach, A., Moritz, T. and Modlich, U. (2014) Clonal dominance with retroviral vector insertions near the ANGPT1 and ANGPT2 genes in a human xenotransplant mouse model. Mol. Ther. Nucleic Acids, 3, e200.
39. Liu, W. and Xie, H. (2013) Predicting potential cancer genes by integrating network properties, sequence features and functional annotations. Sci. China Life Sci., 56, 751-757.
40. Liu, Y., Tian, F., Hu, Z. and DeLisi, C. (2015) Evaluation and integration of cancer gene classifiers: identification and ranking of plausible drivers. Sci. Rep., 5, 10204.
41. List, M., Hauschild, A. C., Tan, Q., Kruse, T. A., Mollenhauer, J., Baumbach, J. and Batra, R. (2014) Classification of breast cancer subtypes by combining gene expression and DNA methylation data. J. Integr. Bioinform., 11, 236.
42. Nayak, L., Tunga, H. and De, R. K. (2013) Disease co-morbidity and the human Wnt signaling pathway: a network-wise study. OMICS, 17, 318-337.
43. Phaltane, R., Haemmerle, R., Rothe, M., Modlich, U. and Moritz, T. (2014) Efficiency and safety of O (6)-methylguanine DNA methyltransferase (MGMT (P140K))-mediated in vivo selection in a humanized mouse model. Hum. Gene Ther., 25, 144-155.
44. Saadatian, Z., Masotti, A., Nariman Saleh Fam, Z., Alipoor, B., Bastami, M. and Ghaedi, H. (2014) Single-nucleotide polymorphisms within micrornas sequences and their 3' UTR target sites may regulate gene expression in gastrointestinal tract cancers. Iran Red Crescent Med. J., 16, e16659.
45. Srivastava, A., Kumar, S. and Ramaswamy, R. (2014) Two-layer modular analysis of gene and protein networks in breast cancer. BMC Syst. Biol., 8, 81.
46. Shangguan, H., Tan, S. Y. and Zhang, J. R. (2015) Bioinformatics analysis of gene expression profiles in hepatocellular carcinoma. Eur. Rev. Med. Pharmacol. Sci., 19, 2054-2061.
47. Yu, H., Mitra, R., Yang, J., Li, Y. and Zhao, Z. (2014) Algorithms for network-based identification of differential regulators from transcriptome data: a systematic evaluation. Sci. China Life Sci., 57, 1090-1102.
48. Olszko, M. E., Adair, J. E., Linde, I., Rae, D. T., Trobridge, P., Hocum, J. D., Rawlings, D. J., Kiem, H. P. and Trobridge, G. D. (2015) Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection. Gene Ther., 22, 591-595.
49. Masson, A. L., Talseth-Palmer, B. A., Evans, T. J., Grice, D. M., Hannan, G. N. and Scott, R. J. (2014) Expanding the genetic basis of copy number variation in familial breast cancer. Hered. Cancer Clin. Pract., 12, 15.
50. Zeller, M., Magnan, C. N., Patel, V. R., Rigor, P., Sender, L. and Baldi, P. (2014) A genomic analysis pipeline and its application to pediatric cancers. IEEE/ACM Trans. Comput. Biol. Bioinformatics, 11, 826-839.
51. Yu, G., Wang, L. G., Yan, G. R. and He, Q. Y. (2015) DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics, 31, 608-609.
52. Collins, F. S. and Varmus, H. (2015) A new initiative on precision medicine. N. Engl. J. Med., 372, 793-795.
53. Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G. et al. (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science, 343, 84-87.
54. Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C. et al. (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 159, 647-661.
55. Wang, T., Wei, J. J., Sabatini, D. M. and Lander, E. S. (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science, 343, 80-84.
56. Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A. and Zhang, F. (2013) Genome engineering using the CRISPR-Cas9 system. Nat. Protoc., 8, 2281-2308.
57. Borah, S., Xi, L., Zaug, A. J., Powell, N. M., Dancik, G. M., Cohen, S. B., Costello, J. C., Theodorescu, D. and Cech, T. R. (2015) Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer. Science, 347, 1006-1010.
58. Vinagre, J., Almeida, A., Populo, H., Batista, R., Lyra, J., Pinto, V., Coelho, R., Celestino, R., Prazeres, H., Lima, L. et al. (2013) Frequency of TERT promoter mutations in human cancers. Nat. Commun., 4, 2185.
59. McGranahan, N. and Swanton, C. (2015) Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell, 27, 15-26.